Adult acne — supplement adjuncts to dermatological care
These supplements are adjuncts to dermatology care, not a replacement — topical retinoids, benzoyl peroxide, hormonal therapy in women and isotretinoin for severe disease produce clearance rates no supplement matches. Zinc has the most direct trial support: zinc gluconate at 30 mg/day has shown non-inferiority to the antibiotic minocycline for inflammatory acne, with omega-3 a reasonable add-on for inflammatory subtypes and a lower-glycaemic diet for high-sugar triggers. Skip the products that backfire, including high-dose biotin and high-dose B12, which can actually trigger acne. Persistent acne with cystic or scarring lesions deserves a dermatologist, and new-onset acne with irregular cycles or hirsutism should prompt a PCOS check rather than self-treatment.
Read this first. Persistent adult acne, particularly with cystic or scarring lesions, deserves dermatology evaluation. New-onset acne in adult women with hirsutism, irregular cycles, or weight gain should prompt PCOS evaluation. Self-treatment with supplements alone in moderate-to-severe disease delays effective treatment and risks scarring.
Supplement adjuncts with mechanism and trial signals
Zinc (gluconate or picolinate)
30 mg elemental zinc/day for 8–12 weeks; cap at 40 mg/day total; reassess and consider copper 1–2 mg/day on chronic use
Zinc gluconate at 30 mg/day has shown non-inferiority to minocycline for inflammatory acne in multiple trials (Dreno 2001). Mechanism likely involves anti-inflammatory and antibacterial effects on Cutibacterium acnes. Picolinate is preferred in dermatology trials. Trial period 8–12 weeks; long-term use requires copper supplementation to prevent depletion.
Omega-3 (EPA/DHA)
1–3 g EPA+DHA daily with meals; choose third-party-tested form
Several small RCTs show modest improvements in inflammatory acne lesion counts with high-dose omega-3 supplementation. Mechanism via reduced inflammatory eicosanoid production. Effect size smaller than topical retinoids but useful as adjunct, particularly in inflammatory-dominant disease.
Myo-inositol (with or without D-chiro-inositol)
2 g myo-inositol twice daily for 12+ weeks; 40:1 myo:DCI ratio in some PCOS protocols
For acne in adult women with concurrent PCOS, insulin resistance, or hyperandrogenism, myo-inositol improves the insulin-resistance metabolic substrate and modestly reduces androgen-mediated acne. Not first-line for acne alone; appropriate when metabolic features are present.
Selected probiotic strains
Lactobacillus / Bifidobacterium multi-strain formula for 8–12 weeks; reassess
Small studies suggest selected probiotic strains may reduce inflammatory acne lesion counts, possibly via gut-skin axis effects. Evidence is preliminary; reasonable adjunct in users with concurrent gut symptoms.
Vitamin D3 (to a target)
Test 25-OH-D and supplement to 30–50 ng/mL; typical maintenance 1,000–2,000 IU/day
Observational associations between low vitamin D and acne severity exist; trial evidence for direct supplementation effect is limited. Test and correct deficiency rather than empirical megadosing.
What to skip — supplements commonly marketed for acne that don't deliver
- High-dose biotin — no evidence base for acne; can worsen acne in some users via altered B-vitamin balance; interferes with thyroid and troponin assays.
- Vitamin B12 high-dose — has triggered acneiform eruptions in case reports; avoid high-dose B12 supplementation in active acne unless treating documented deficiency.
- "Hormonal balance" herbal stacks for women — typically contain inconsistent doses of vitex, dong quai, black cohosh; under-trialled for acne specifically; risk of disrupting other hormonal therapies.
- "Detox" / "liver cleanse" supplements — acne is not a liver-detox disorder; mechanism doesn't apply.
- Iodine supplementation — high iodine intake can trigger acneiform eruptions; avoid kelp or high-iodine supplements unless treating documented deficiency.
- Whey protein in users with persistent acne — observational data suggest whey may worsen acne in susceptible users via IGF-1 signalling; consider trial period off whey if acne persists despite optimised dermatology care.
- "Acne supplement" multi-ingredient formulas at premium prices — typically under-dose every active ingredient.
The dietary layer with real signal
- Low-glycaemic-load eating pattern — multiple trials show low-GL diets reduce acne lesion counts. The Smith 2007 trial in male teens showed clear improvements; subsequent meta-analyses align.
- Reduced dairy intake — skim milk in particular is associated with acne in cohort studies. Trial removal for 8–12 weeks if persistent acne despite dermatology care.
- Reduced whey protein and high-IGF-1-stimulating foods — same mechanism; relevant in athletes with persistent acne.
The dermatology layer that dominates everything
- Topical retinoids (tretinoin, adapalene, tazarotene) — first-line; nightly application with gradual ramp-up.
- Topical benzoyl peroxide 2.5–10% — reduces bacterial load; pairs well with retinoids.
- Topical antibiotics (clindamycin, erythromycin) — short courses combined with BPO to limit resistance.
- Oral hormonal therapy in women (combined OCPs, spironolactone) — for hormonally-driven adult female acne.
- Oral isotretinoin — for moderate-to-severe nodulocystic disease or recalcitrant disease; dermatologist-managed.
Practical quick-start. Coordinate the dermatology protocol — topical retinoid + BPO is first-line. Add zinc 30 mg/day for 8–12 weeks as the highest-evidence supplement adjunct. Consider omega-3 1–2 g EPA+DHA daily for inflammatory subtypes. Adopt a low-glycaemic-load eating pattern. Trial removing skim milk and whey if acne persists despite optimised dermatology care. Get evaluation for PCOS / hormonal drivers in adult women with new-onset or persistent acne plus other hyperandrogen features.
What to track
Lesion count and severity (IGA — Investigator Global Assessment) at baseline and follow-up. Photos at standardised lighting and distance. For users with hormonal features: cycle history, total/free testosterone, DHEAS, SHBG, 17-OH-progesterone (with prescriber). For users on isotretinoin: monthly liver function, lipid panel, pregnancy testing per iPLEDGE protocol. For users on chronic zinc above 30 mg/day: serum copper at 6 months.